Journals / Turkish Journal of Medical Sciences / 2003 / Cilt: 33 - Sayı: 1

Diagnostic value of Ki-67LI in hepatocellular carcinoma; Ki-67 antigen expression in hepatocellular carcinoma, metastatic adenocarcinoma and normal hepatocytes

Pages
15–19
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In additions, the numbers of hepatocytes positive for Ki-67 has a good correlation with the degree of differentiation of HCC (t = 2.96, p < 0.01).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:One hundred liver fine-needle aspiration cytology (FNAC) specimens obtained from 42 patients with hepatocellular carcinomas (HCC), 38 patients with metastatic adenocarcinomas (MAC) and 20 patients with non-malignant liver disease (control group) were studied.
📊
Key Findings & Data:Liver specimens were stained with an immunoperoxidase method using a monoclonal antibody to Ki-67 (MIB1).
💡
Conclusion & Impact:In additions, the numbers of hepatocytes positive for Ki-67 has a good correlation with the degree of differentiation of HCC (t = 2.96, p < 0.01).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

One hundred liver fine-needle aspiration cytology (FNAC) specimens obtained from 42 patients with hepatocellular carcinomas (HCC), 38 patients with metastatic adenocarcinomas (MAC) and 20 patients with non-malignant liver disease (control group) were studied. Liver specimens were stained with an immunoperoxidase method using a monoclonal antibody to Ki-67 (MIB1). Ki-67 antigen was visualised in cold acetone, and a fresh liver needle aspiration cytology specimen using antibodies was used to identify proliferating hepatocytes. In this study it was examined that; if there is a difference between the groups in terms of Ki-67 positivity and degree of differentiation of tumor and the relationship there in. The Ki-67 labeling index (LI) of HCC cases was significantly different from the other two groups (p < 0.01). In additions, the numbers of hepatocytes positive for Ki-67 has a good correlation with the degree of differentiation of HCC (t = 2.96, p < 0.01).

🔖

Cite This Article

EKİNCİ, C., KAYA, M., BAHAR, K., GENÇ, Y., SOYUER, I. (2022). Diagnostic value of Ki-67LI in hepatocellular carcinoma; Ki-67 antigen expression in hepatocellular carcinoma, metastatic adenocarcinoma and normal hepatocytes. Turkish Journal of Medical Sciences, Cilt: 33 - Sayı: 1, 15–19. https://ajindex.com/articles/612145

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Ouchi K, Sugawara T, Ono H, Fujiya T, et al. Mitotic index is the best predictive factor for survival of patients with resected hepatocellular carcinoma. Dig Surg 17(1):42-8, 2000 2. Suehiro T, Marsumata T, Itaska H et al: Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen. Cancer 76: 399-405, 1995 3. Chapel F, Guettier C, Chastang C et al. Cancer 77: 864-871, 1996 4. Ojanguren I, ArÝza A, Llatjos M et al: Proliferating cell nuclear antigen expression in normal, regenerative and neoplastic liver. Hum Pathol 24: 905- 908,1993 5. Hino N, Higashi T, Nouso K et al: Proliferating cell nuclear antigen and Grade of malignancy in small hepatocellular carcinoma - Evaluation in US guided specimens-Hepatogastroenterology 44: 245-250, 1997 6. Souni Y, Virkajarvi N, Lehto VP et al: Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shorthened survival. Br J Cancer 73: 1025-1030, 1996 7. Kitamoto M, Nakanishi T, Kira S et al: The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis. Cancer 72: 1859-1865, 1993 8. Soulier JP, Gozin D, LeFrere JJ: A new method to assay des-d- carboxyprothrombin: Result obtained in 75 cases of hepatocellular carcinoma. Gastroenterology 91: 125-1262, 1986 9. Ojanguren I, Jastella E, Lladjos M et al: p53 immunoreaction in hapatocellular carcinoma and its relationship to etiologic factors. Acta Cytol 40: 1148- 1153, 1996 10. Farinati F, Cardin R, Derrico A et al: Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki-67 in archival material: the role of etiology, disease activity, iron and lipid peroxidation. Hepatology 23: 1468- 1475, 1996 11. Ng IOL, Ng M, Fan ST: Better survival in women with resected hepatocellular carcinoma is not related to tumor proliferation or expression of hormone receptors. The Am J Gastroenterol 92: 1355-1358, 1997 12. Kaita KD, Pettigrew N, Minuk GY: Hepatic regeneration in humans with various liver disease as assessed by Ki- 67 staining of formalin-fixed paraffin embedded liver tissues. Liver 17:13-16, 1997 13. Tiniakos DG, Brunt EM Proliferating cell nuclear antigen and Ki-67 lebeling in hepatocellular nodules: a comparative study. Liver 19 (1): 58-68, 1999 14. Kin